No connection

Search Results

Analysis Neutral

Radiopharm Theranostics Signs Supply Deal With Siemens Healthineers For RAD101

Apr 07, 2026 12:01 UTC

(RTTNews) - Radiopharm Theranostics Ltd.

  • April 07, 2026 — 08:01 am EDT Written byRTTNews
  • comforRTTNews-> (RTTNews) - Radiopharm Theranostics Ltd
  • (RADX) said Tuesday it has signed a supply agreement with Siemens Healthineers for RAD101, a novel imaging small molecule targeting fatty acid synthase (FASN) to diagnose suspected recurrent brain metastases from solid tumors

April 07, 2026 — 08:01 am EDT Written byRTTNews.comforRTTNews-> (RTTNews) - Radiopharm Theranostics Ltd. (RADX) said Tuesday it has signed a supply agreement with Siemens Healthineers for RAD101, a novel imaging small molecule targeting fatty acid synthase (FASN) to diagnose suspected recurrent brain metastases from solid tumors. Under the agreement, Siemens Healthineers will manufacture and distribute Fluorine-18-labeled RAD101 to support Radiopharm's upcoming Phase 3 trial in the U.S. Interim Phase 2b data showed significant and selective tumor uptake in brain metastases, with 90% concordanc

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile